DArecca James
Insider CIK 1583903 · PBH Director · ACT VP, CHIEF ACCOUNTING OFFICER · TXMD Chief Financial Officer · HAE EVP, Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| PBH Prestige Consumer Healthca | A Award | 2026-08-04 | 2026-08-05 | 2,981 | — | $0 | 9,572 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2026-08-04 | 2026-08-05 | 2,981 | — | $0 | 9,572 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2026-05-15 | 2026-05-19 | 29,312 | — | $0 | 54,444 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2026-05-15 | 2026-05-19 | 2,505 | $56.29 | $141.0K | 25,132 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2026-05-01 | 2026-05-05 | 655 | $59.26 | $38.8K | 27,637 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2025-08-05 | 2025-08-06 | 2,094 | — | $0 | 6,591 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2025-05-30 | 2025-06-03 | 12,221 | — | $0 | 34,156 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2025-05-30 | 2025-06-03 | 5,864 | $69.38 | $406.8K | 28,292 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2025-05-16 | 2025-05-20 | 15,396 | — | $0 | 15,396 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2025-05-16 | 2025-05-19 | 1,246 | $70.31 | $87.6K | 14,824 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2025-05-16 | 2025-05-20 | 7,111 | — | $0 | 21,935 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2025-05-15 | 2025-05-19 | 622 | $69.38 | $43.2K | 16,070 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2025-05-02 | 2025-05-05 | 654 | $63.85 | $41.8K | 16,692 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2024-08-06 | 2024-08-07 | 2,202 | — | $0 | 4,497 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2024-05-17 | 2024-05-21 | 9,756 | — | $0 | 9,756 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2024-05-17 | 2024-05-21 | 4,439 | — | $0 | 17,346 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2024-05-16 | 2024-05-17 | 351 | $94.80 | $33.3K | 12,907 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2024-05-15 | 2024-05-17 | 412 | $96.49 | $39.8K | 13,258 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2024-05-02 | 2024-05-06 | 432 | $93.33 | $40.3K | 13,670 | SEC↗ |
| PBH Prestige Consumer Healthca | A Award | 2023-08-01 | 2023-08-03 | 2,295 | — | $0 | 2,295 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2023-05-16 | 2023-05-17 | 349 | $89.21 | $31.1K | 14,102 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2023-05-15 | 2023-05-17 | 9,502 | — | $0 | 9,502 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2023-05-15 | 2023-05-17 | 4,205 | — | $0 | 14,451 | SEC↗ |
| HAE HAEMONETICS CORP | F Tax w/h | 2023-05-02 | 2023-05-04 | 430 | $81.66 | $35.1K | 10,246 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2022-05-16 | 2022-05-18 | 11,163 | — | $0 | 11,163 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2022-05-16 | 2022-05-18 | 4,774 | — | $0 | 10,676 | SEC↗ |
| HAE HAEMONETICS CORP | A Award deriv | 2022-05-02 | 2022-05-04 | 13,828 | — | $0 | 13,828 | SEC↗ |
| HAE HAEMONETICS CORP | A Award | 2022-05-02 | 2022-05-04 | 5,902 | — | $0 | 5,902 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | S Sale | 2021-08-12 | 2021-08-12 | 93,337 | $0.87 | $81.2K | 123,830 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise deriv | 2021-08-10 | 2021-08-12 | 217,167 | — | $0 | 434,333 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | M Exercise | 2021-08-10 | 2021-08-12 | 217,167 | — | $0 | 217,167 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 346,667 | — | $0 | 346,667 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2021-07-01 | 2021-07-02 | 173,333 | — | $0 | 173,333 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-08-07 | 151,500 | — | $0 | 151,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-08-07 | 651,500 | — | $0 | 651,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 151,500 | — | $0 | 151,500 | SEC↗ |
| TXMD TherapeuticsMD, Inc. | A Award deriv | 2020-06-18 | 2020-06-19 | 651,500 | — | $0 | 651,500 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 3,534 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 4,957 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer deriv | 2020-05-08 | 2020-05-11 | 1,169 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 3,511 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | D To issuer | 2020-05-08 | 2020-05-11 | 6,324 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2020-03-06 | 2020-03-10 | 718 | $191.95 | $137.8K | 9,834 | SEC↗ |
| AGN Allergan plc | A Award | 2020-03-02 | 2020-03-04 | 3,611 | $193.84 | $700.0K | 10,552 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-12-31 | 2020-01-02 | 92 | $191.17 | $17.6K | 6,941 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-03-08 | 2019-03-11 | 113 | $145.06 | $16.4K | 7,033 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-03-07 | 2019-03-11 | 359 | $143.00 | $51.3K | 7,146 | SEC↗ |
| AGN Allergan plc | A Award | 2019-03-06 | 2019-03-08 | 2,036 | $137.51 | $280.0K | 7,505 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2019-03-04 | 2019-03-06 | 114 | $139.12 | $15.9K | 5,469 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-12-31 | 2019-01-03 | 147 | $133.66 | $19.6K | 5,453 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-03-08 | 2018-03-09 | 79 | $153.50 | $12.1K | 5,600 | SEC↗ |
| AGN Allergan plc | A Award | 2018-03-07 | 2019-03-06 | 1,826 | $153.22 | $279.8K | 5,809 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-03-07 | 2018-03-08 | 93 | $153.22 | $14.2K | 3,983 | SEC↗ |
| AGN Allergan plc | A Award | 2018-03-07 | 2018-03-08 | 1,696 | $153.22 | $259.9K | 5,679 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-03-05 | 2018-03-06 | 70 | $148.73 | $10.4K | 4,076 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2018-03-02 | 2018-03-06 | 76 | $144.02 | $10.9K | 4,146 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-12-29 | 2018-01-02 | 100 | $163.58 | $16.4K | 4,222 | SEC↗ |
| AGN Allergan plc | M Exercise deriv | 2017-10-26 | 2017-10-30 | 799 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | M Exercise | 2017-10-26 | 2017-10-30 | 799 | — | $0 | 4,322 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-03-08 | 2017-03-09 | 77 | $239.44 | $18.4K | 3,523 | SEC↗ |
| AGN Allergan plc | A Award | 2017-03-07 | 2017-03-09 | 1,085 | $239.60 | $260.0K | 3,600 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-03-05 | 2017-03-07 | 66 | $245.63 | $16.2K | 2,515 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-03-04 | 2017-03-07 | 72 | $245.63 | $17.7K | 2,581 | SEC↗ |
| AGN Allergan plc | C Conversion deriv | 2017-02-01 | 2017-02-03 | 238 | — | $0 | 0 | SEC↗ |
| AGN Allergan plc | A Award | 2017-02-01 | 2017-02-03 | 238 | $229.32 | $54.6K | 2,745 | SEC↗ |
| AGN Allergan plc | F Tax w/h | 2017-02-01 | 2017-02-03 | 92 | $229.32 | $21.1K | 2,653 | SEC↗ |
| AGN Allergan plc | A Award | 2016-03-08 | 2016-05-12 | 914 | $284.43 | $260.0K | 2,507 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 33 | $295.70 | $9.8K | 1,182 | SEC↗ |
| ACT Actavis plc | A Award | 2015-03-05 | 2015-03-09 | 456 | — | $0 | 1,638 | SEC↗ |
| ACT Actavis plc | F Tax w/h | 2015-03-05 | 2015-03-09 | 45 | $295.70 | $13.3K | 1,593 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2015-03-04 | 2015-03-06 | 1,169 | — | $0 | 1,169 | SEC↗ |
| ACT Actavis plc | A Award | 2015-03-04 | 2015-03-06 | 877 | $296.14 | $259.7K | 1,215 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 4,957 | — | $0 | 4,957 | SEC↗ |
| ACT Actavis plc | A Award deriv | 2014-07-01 | 2014-07-03 | 1,816 | — | $0 | 1,816 | SEC↗ |
| ACT Actavis plc | A Award | 2014-05-09 | 2014-05-13 | 338 | $197.05 | $66.6K | 338 | SEC↗ |